THYROID EYE DISEASE (TED) SIGNS AND SYMPTOMS IDENTIFICATION TOOL

Use this identification tool to recognize the signs and symptoms of TED in your patients

TED is a serious autoimmune disease with heterogenous presentation among patients.1 Early TED signs and symptoms may present like dry eye disease, allergies, or conjunctivitis.2-4 Use the tool below to explore TED signs and symptoms, see the impact TED can have on daily activities, and view questions to help initiate conversation with your patients.

Select one or more signs and symptoms that your patient is experiencing to create a personalized sheet for your patient.

Checklist icon
orbital-fibroblasts-and-inflammation-thyroid-eye-disease-pathophysiology
Learn about the cause of TED

See the changes occurring behind the eye before visual signs appear

Next Page    >    Learn about the signs and symptoms of TED

Sign Up

Receive the latest news and updates about Thyroid Eye Disease (TED).

Sign Up

REFERENCES
  1. Wang Y, Patel A, Douglas RS. Thyroid Eye Disease: how a novel therapy may change the treatment paradigm. Ther Clin Risk Manag. 2019;15:1305-1318.
  2. Couch SM. Thyroid Eye Disease: timely diagnosis is key to controlling this autoimmune condition. Glaucoma Today. January/February 2019. Accessed January 20, 2023. https://assets.bmctoday.net/glaucomatoday/pdfs/0119GT_F2_Couch.pdf
  3. Estcourt S, Hickey J, Perros P, Dayan C, Vaidya B. The patient experience of services for Thyroid Eye Disease in the United Kingdom: results of a nationwide survey. Eur J Endocrinol. 2009;161(3):483-487.
  4. Liaboe CA, Clark TJ, Simmons BA, Carter K, Shriver EM. Thyroid Eye Disease: an introductory tutorial and overview of disease. April 23, 2020. Accessed January 24, 2023. https://eyerounds.org/tutorials/thyroid-eye-disease/index.htm
  5. Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol. 2015;2015:249125.
  6. Dolman PJ. Grading severity and activity in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2018;34(4S suppl 1):S34-S40.
  7. Kahaly GJ, Petrak F, Hardt J, Pitz S, Egle UT. Psychosocial morbidity of Graves’ orbitopathy. Clin Endocrin (Oxf). 2005;63(4):395-402.
  8. Estcourt S, Vaidya B, Quinn A, Shepherd M. The impact of Thyroid Eye Disease upon patients’ wellbeing: a qualitative analysis. Clin Endocrinol (Oxf). 2008;68(4):635-639.
  9. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long-term effects of Graves’ ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146(6):751-757.
  10. Bahn RS. Graves’ ophthalmopathy. N Engl J Med. 2010;362(8):726-738.
  11. Bartley GB, Fatourechi V, Kadrmas EF, et al. Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmol. 1996;103(6):958-962.
  12. Cockerham KP, Padnick-Silver L, Stuertz N, Francis-Sedlak M, Holt RJ. Quality of life in patients with chronic Thyroid Eye Disease in the United States. Ophthalmol Ther. 2021;10(4):975-987.
  13. Eyelid Dermatitis. Cleveland Clinic. Accessed April 26, 2024. https://my.clevelandclinic.org/health/diseases/21930-eyelid-dermatitis
  14. Bothun ED, Scheurer RA, Harrison AR, Lee MS. Update on Thyroid Eye Disease and management. Clin Ophthalmol. 2009;3:543-551.
  15. Chemosis. Mt Sinai. Accessed April 26, 2024. https://www.mountsinai.org/health-library/symptoms/chemosis#:~:text=Chemosis
  16. Eye Pain. eMedicineHealth. Accessed April 26, 2024. https://www.emedicinehealth.com/eye_pain/article_em.htm
  17. Thyroid Eye Disease (TED) fact sheet. PreventBlindness.org. Accessed June 8, 2022. https://www.preventblindness.org/thyroid-eye-disease
  18. Verity DH, Rose GE. Acute Thyroid Eye Disease (TED): principles of medical and surgical management. Eye (Lond). 2013;27(3):308-319.
  19. American Thyroid Association. Graves’ eye disease brochure. Accessed September 1, 2022. https://www.thyroid.org
  20. McAlinden C. An overview of Thyroid Eye Disease. Eye Vis (Lond). 2014;1:9.